MMCM
ZBH icon

Murphy & Mullick Capital Management’s Zimmer Biomet ZBH Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.5K Hold
912
– – 0.06% 219
2025
Q4 		$82K Sell
912
-430
-32% -$40.8K 0.06% 217
2025
Q3 		$132K Hold
1,342
– – 0.1% 173
2025
Q2 		$123K Hold
1,342
– – 0.1% 166
2025
Q1 		$152K Hold
1,342
– – 0.15% 143
2024
Q4 		$142K Buy
+1,342
New +$144K 0.13% 149

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Murphy & Mullick Capital Management's ZBH Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 912 shares worth $82.5K. The position accounts for 0.06% of the portfolio, ranked #219.

Murphy & Mullick Capital Management first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $152K in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Murphy & Mullick Capital Management held 912 shares of Zimmer Biomet worth $82.5K as of Q1 2026.
  • Murphy & Mullick Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.06% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #219 holding.
  • Murphy & Mullick Capital Management first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's Zimmer Biomet position peaked at $152K in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.